Compare WCC & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WCC | ELAN |
|---|---|---|
| Founded | 1922 | 1954 |
| Country | United States | United States |
| Employees | 21000 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 12.7B |
| IPO Year | N/A | 2018 |
| Metric | WCC | ELAN |
|---|---|---|
| Price | $304.44 | $23.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $271.50 | $27.63 |
| AVG Volume (30 Days) | 456.1K | ★ 5.5M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $8.40 | $8.21 |
| Revenue Next Year | $5.40 | $5.29 |
| P/E Ratio | $23.12 | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $142.14 | $8.02 |
| 52 Week High | $319.68 | $27.72 |
| Indicator | WCC | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 65.25 | 48.56 |
| Support Level | $244.62 | $22.17 |
| Resistance Level | $319.68 | $23.70 |
| Average True Range (ATR) | 10.07 | 1.02 |
| MACD | 4.99 | -0.02 |
| Stochastic Oscillator | 96.28 | 43.30 |
Wesco can be traced back to the late 1800s but was officially founded in 1922, acting as the distribution arm of Westinghouse Electric. Throughout the 1900s, Wesco entered and subsequently exited the consumer electronics, transit, bottling, and nuclear plant distribution markets. It was sold to a private equity firm in 1994 and then went public in 1999, and numerous acquisitions have since been made to fill the gaps in Wesco's geographical and product coverage. Today, the firm primarily distributes electrical, networking, security, and utility equipment used in the construction and repair of structures such as offices, data centers, power transmission lines, and manufacturing plants. Wesco has operations around the globe but generates the majority of its revenue in the United States.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.